| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/26/2000 | EP0973926A1 Adenoviral vectors with modified tropism |
| 01/26/2000 | EP0973890A2 Secreted proteins and polynucleotides encoding them |
| 01/26/2000 | EP0973789A1 Novel phosphate compounds and their use as medicaments |
| 01/26/2000 | EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/26/2000 | EP0973741A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 01/26/2000 | EP0973733A1 Bis-sulfonomides hydroxamic acids as mmp inhibitors |
| 01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
| 01/26/2000 | EP0973532A1 Anti-proliferative preparations |
| 01/26/2000 | EP0973531A1 Facilitation of wound healing with cm101/gbs toxin |
| 01/26/2000 | EP0973529A2 Essential oil composition |
| 01/26/2000 | EP0973524A1 Cosmetic or dermatological use of 7-hydroxylated steroids |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973495A1 Use of bambara nut seed extract(s) in a cosmetic composition |
| 01/26/2000 | EP0973485A2 Cosmetic and dermatological agent with a hard-magnetic particle base |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0973390A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease |
| 01/26/2000 | CN1242696A Compositions contg. antifungal and phospholipid |
| 01/26/2000 | CN1242235A Oily medicine for treating burns |
| 01/26/2000 | CN1242232A Pharmaceutical prescription for treating psoriasis |
| 01/26/2000 | CN1242226A Traditional Chinese medicine composition for treating scabies, and method for preparing same |
| 01/26/2000 | CN1242205A Pharmaceutical composition for treating bed sore and ulcerous wound surface |
| 01/25/2000 | US6017907 Structural analogues of vitamin D |
| 01/25/2000 | US6017889 Metalloproteinase inhibitors |
| 01/25/2000 | US6017888 Stimulation of hair growth by peptide copper complexes |
| 01/25/2000 | US6017731 Nucleotide sequences encoding a signal sequence, a propeptide leader sequence, a preferred processing site cleaved in situ by a yeast proteolytic enzyme; expressing mammalian proteins and their secretion in a biologically active mature form |
| 01/25/2000 | US6017727 Syndecan enhancer element and syndecan stimulation of cellular differentiation |
| 01/25/2000 | US6017551 Mixture of naturally occurring neutral organic glyceryl esters of fatty acids, such as lard; for treating discomfort due to burned, inflamed or irritated skin |
| 01/25/2000 | US6017531 An extracellular neutral protease and a stabilizer of glyceryl cocoate as a wound healing agent and for debriding necrotic tissue; storage stable enzyme activity at room temperature; burns; cutaneous ulcers; pressure necroses incisional, |
| 01/24/2000 | CA2277703A1 New 2-amino, 4-alkylamino pyrimidine 3-oxides and composition comprising them |
| 01/21/2000 | CA2277894A1 Aqueous single phase transparent cosmetic composition |
| 01/20/2000 | WO2000003036A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | WO2000003014A1 Pharmaceutical uses of nab1 and nab2 |
| 01/20/2000 | WO2000002923A1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 01/20/2000 | WO2000002917A2 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | WO2000002904A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 01/20/2000 | WO2000002871A1 Novel angiogenesis inhibitors |
| 01/20/2000 | WO2000002839A1 Cytokine production and tyrosine kinase inhibitors |
| 01/20/2000 | WO2000002583A1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 01/20/2000 | WO2000002579A2 Component b as angiogenic agent in combination with human growth factors |
| 01/20/2000 | WO2000002577A1 Therapeutic use of uncoupling protein hhfcw60 |
| 01/20/2000 | WO2000002570A1 Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them |
| 01/20/2000 | WO2000002563A1 Steroid-containing cataplasms and process for producing the same |
| 01/20/2000 | WO2000002548A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 01/20/2000 | WO2000002544A2 Use of piperine for treating skin pigmentation disorders |
| 01/20/2000 | WO1999059610A3 Use of lipopeptides or lipoproteins for wound treatment |
| 01/20/2000 | WO1999055347A3 Treatment of papilloma virus infection using a mycobacterium |
| 01/20/2000 | WO1999053943A3 Therapeutic angiogenic factors and methods for their use |
| 01/20/2000 | CA2336848A1 Novel angiogenesis inhibitors |
| 01/20/2000 | CA2336805A1 Pharmaceutical uses of nab1 and nab2 |
| 01/20/2000 | CA2335382A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | CA2333928A1 Compounds and methods for modulating cadherin-mediated functions |
| 01/19/2000 | EP0972762A2 Novel structural analogues of vitamin D |
| 01/19/2000 | EP0972521A1 Pharmaceutical composition containing stimulators of interferon-gamma |
| 01/19/2000 | EP0972511A1 Association of a retinoid with a histidine derivative |
| 01/19/2000 | EP0972052A1 Keratinocyte derived kallikrein |
| 01/19/2000 | EP0972042A1 Polypeptide expressed in the horny layer of epidermis and use thereof |
| 01/19/2000 | EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 01/19/2000 | EP0972026A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0971961A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
| 01/19/2000 | EP0971955A1 Secreted proteins |
| 01/19/2000 | EP0971950A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971921A1 2-aryl-naphthyridin-4-ones as antitumor agents |
| 01/19/2000 | EP0971909A1 Lta 4? hydrolase inhibitors |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971901A1 Phthalazinones |
| 01/19/2000 | EP0971895A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 01/19/2000 | EP0971894A1 Nicotinamide derivatives |
| 01/19/2000 | EP0971888A1 2-alkyl-19-nor-vitamin d compounds |
| 01/19/2000 | EP0971883A1 Retinoid-like compounds |
| 01/19/2000 | EP0971873A1 Asiatic acid derivatives and medicines for treating wounds, which contains the same |
| 01/19/2000 | EP0971746A1 Solvent system for enhanced penetration of pharmaceutical compounds |
| 01/19/2000 | EP0971725A1 Methods for treatment of scar tissue |
| 01/19/2000 | EP0971721A1 Use of bacterial cell wall extract for preventing, treating, or eliminating a protozoal or parasitic disease |
| 01/19/2000 | EP0971720A1 Use of bacterial cell wall extracts for treating topical disorders and wounds |
| 01/19/2000 | EP0971687A1 Aqueous solutions of salicylic acid derivatives |
| 01/19/2000 | EP0971680A1 Composition to stop hairloss |
| 01/19/2000 | EP0859751B1 Semi-fluorinated alkanes and their use |
| 01/19/2000 | EP0809623B1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them |
| 01/19/2000 | CN1241999A Vitamin D3 derivatives |
| 01/19/2000 | CN1241558A Bicyclic aromatic compound and its application in human medicines or animal medicines and cosmetics teconology |
| 01/19/2000 | CN1241436A Acne treating Chinese medicine preparation |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015678 Method for detection of a polynucleotide encoding protein kinase C inhibitor-homolog |
| 01/18/2000 | US6015578 Trapidil for use in the therapy of syndrome that may be influenced by immunomodulators |
| 01/18/2000 | US6015569 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/18/2000 | US6015568 Anhydrous stable retinol based cosmetic or pharmaceutical composition |
| 01/18/2000 | CA2184433C Retinoid formulations in porous microspheres for reduced irritation and enhanced stability |
| 01/18/2000 | CA2147089C Cosmetic and/or dermatological composition containing a glycerol tri(alpha-hydroxyacylate) as the only glycerol precursor |
| 01/13/2000 | WO2000001815A2 Neurotrophic factors |
| 01/13/2000 | WO2000001690A1 Cinnamic acid derivatives as cell adhesion molecules |
| 01/13/2000 | WO2000001676A1 Potassium channel blocking agents |
| 01/13/2000 | WO2000001395A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 01/13/2000 | WO2000001351A1 Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
| 01/13/2000 | WO1999055312A3 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 01/13/2000 | CA2335920A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 01/12/2000 | EP0970701A2 Pellets derived from keratinocytes for use as wound healing substances |
| 01/12/2000 | EP0970700A2 Gallium containing medicaments for enhancing wound healing and tissue repair |
| 01/12/2000 | EP0970691A1 Composition for topical application containing a lipase, vitamin precursor and a fatty alcohol |
| 01/12/2000 | EP0970685A1 Composition for dyeing keratinous fibres containing a cationic direct dye and a thickening polymer |